Skip to content

Paracetamol (Acetaminophen) In Stroke

Paracetamol (Acetaminophen) In Stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN74418480
Enrollment
2500
Registered
2002-11-06
Start date
2003-05-01
Completion date
Unknown
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute stroke Circulatory System Cerebrovascular diseases

Interventions

Treatment with high dose paracetamol (6 g/day) or placebo will start within 12 hours after onset of symptoms, and continue for three days.

Sponsors

Erasmus Medical Center (The Netherlands)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Clinical diagnosis of acute stroke 2. Possibility to start treatment within 12 hours from onset 3. Brain Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) within 24 hours 4. Age 18 years or older 5. Signed informed consent

Exclusion criteria

Exclusion criteria: Abody temperature lower than 36¡ãC or higher than 39¡ãC A history of liver disease Alcohol abuse 1. Liver enzymes increased above twice the upper limit of normal 2. Allergy to paracetamol 3. Significant pre-stroke impairment (more than three on the modified Rankin Scale [mRS])

Design outcomes

Primary

MeasureTime frame
Dichotomised mRS (less than or equal to two: good outcome, more than or equal to six: poor outcome) at three months.

Secondary

MeasureTime frame
1. Score on the Barthel index after two weeks 2. Body temperature after 24 hours of treatment 3. EuroQol-5D instrument at three months

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 3, 2026